BMJ  2006;332:61-62 (14 January), doi:10.1136/bmj.332.7533.61

Editorial

When to test women for human papillomavirus

Cervical screening using HPV testing shows great promise but warrants caution

The first 150 words of the full text of this article appear below.

Increased understanding of human papilloma-viruses (HPV) and cervical carcinogenesis has led to prevention strategies that are very promising. Two articles in this issue (pp 79, 83) find that DNA testing for HPV is a cost effective way to clarify the meaning of equivocal results of cervical cytology.^{1 2}

Cervical HPV infections are very common, particularly among young women, and are sexually transmitted.³ They usually clear within one or two years. However, persistent infections by 15 or so carcinogenic HPV genotypes cause most cases of cervical precancer, which is generally diagnosed years after the causal infection, and of invasive cancer, which is typically diagnosed at least two decades after infection.⁴

Reproducible methods for testing for HPV are already available that are more sensitive (but less specific) than cytology for detecting prevalent and incipient precancer and cancer.⁵ Testing for HPV might be used to improve the four sequential steps of . . . [Full text of this article]

Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA
(schiffmm@mail.nih.gov)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Articles

Hit Parade
BMJ 2006 332: 496. [Extract] [Full Text]

Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studies

Rosa Legood, Alastair Gray, Jane Wolstenholme, and Sue Moss
BMJ 2006 332: 79-85. [Abstract] [Full Text] [PDF]

Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after study

Sue Moss, Alastair Gray, Rosa Legood, Martin Vessey, Julietta Patnick, Henry Kitchener Liquid Based Cytology/Human Papillomavirus Cervical Pilot Studies Group
BMJ 2006 332: 83-85. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

• (2006). Hit Parade. BMJ 332: 496-496 [Full text]